tert-butyl (3S)-3-(1H-pyrazol-5-yl)azepane-1-carboxylate, 98%, 1g

2-[[(Ethylthio)carbonothioyl]thio]-2-methylpropanoic Acid>98.0%(HPLC)(T)5g

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 5g

GC capillary column ROTI®Cap-1, 50 m, 0.32 mm, 5.00 µm, 1 Piece(s)

1-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic acid, 95.0%, 100mg

4-Chloro-6-fluoro-quinoline-3-carbonitrile, 97.0%, 1g

[3-(2-AMINO-1-METHYLETHOXY)PHENYL]DIMETHYLAMINE, 95.0%, 250mg

4,4'-(Diphenylmethylene)diphenol, 95.0%, 25g

(5E)-5-(2,4-dimethylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

ETHYL 2-(PYRAZIN-2-YL)ACETATE, 97.0%, 5g

3,5-Bis(trifluoromethyl)bromobenzene, 98.0%, 1kg

3-(1-METHYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE-6-CARBONITRILE, 97.0%, 1g

3-Fluoro-2-nitrobenzonitrile, 95.0%, 5g